Resources

File Name Product Name Date
Announcement - 2020 Annual Report ChinaAMC China Focus Fund 20-04-2021 Download >
2020 Annual Report ChinaAMC China Focus Fund 20-04-2021 Download >
Announcement - 2020 Annual Report 20-04-2021 Download >
Announcement - 2020 Annual Report ChinaAMC Global Investment Grade Bond Fund 20-04-2021 Download >
Notice to Unitholders ChinaAMC Return Securities Investment Fund 14-04-2021 Download >
Notice to Unitholders ChinaAMC Return Securities Investment Fund 09-04-2021 Download >
Announcement - Distribution Announcement 09-04-2021 Download >
Notice to Unitholders ChinaAMC Xinghua Mixed Securities Investment Fund 09-04-2021 Download >
Notice to Unitholders ChinaAMC Xinghua Mixed Securities Investment Fund 07-04-2021 Download >
Notice to Unitholders ChinaAMC Return Securities Investment Fund 02-04-2021 Download >
Notice to Unitholders ChinaAMC Xinghua Mixed Securities Investment Fund 02-04-2021 Download >
2020 Annual Report ChinaAMC Xinghua Mixed Securities Investment Fund 30-03-2021 Download >
2020 Annual Report ChinaAMC Return Securities Investment Fund 30-03-2021 Download >
Announcement - 2020 Annual Report and Summary ChinaAMC Return Securities Investment Fund 30-03-2021 Download >
Announcement - Notice To Unitholders - PAYMENT OF DIVIDENDS ChinaAMC Select RMB Bond Fund 30-03-2021 Download >
Announcement - 2020 Annual Report and Summary ChinaAMC Xinghua Mixed Securities Investment Fund 30-03-2021 Download >
Announcement - Clarification of Investment Strategy 22-03-2021 Download >
Announcement - Indicative Net Asset Value of the Sub-Funds ChinaAMC Hang Seng Hong Kong Biotech Index ETF (3069 HK / 9069 HK / 83069 HK) 17-03-2021 Download >
Brochure ChinaAMC Hang Seng Hong Kong Biotech Index ETF (3069 HK / 9069 HK / 83069 HK) 17-03-2021 Download >
Notice to Unitholders ChinaAMC Xinghua Mixed Securities Investment Fund 12-03-2021 Download >

Important Notes:

Add Your Heading Text Here

Important Notes:

Private Funds

ChinaAMC(HK) is uniquely positioned in the market which enables it to leverage its extensive knowledge, research capabilities and investment experience in China to deliver a range of high-value asset management or investment advisory services to institutional clients worldwide. To bridge overseas investors with China opportunities, ChinaAMC (HK) is committed to utilize its local expertise to capture enormous investment potentials in China.

The private fund products issued and managed by ChinaAMC (HK) include Cayman Islands registered funds and Luxembourg domiciled SICAV funds*.

Browse through our website and discover our investment strategies. For private fund products information, please visit the product page by logging into your account.

* SICAV fund is an open-ended collective investment scheme common in Western Europe and may be open to public investors in certain European countries depending on its registration status.

Welcome back

Lorem ipsum dolor sit amet, conse ctetuer adipi scing elitenean.